Revolution Medicines (RVMD) | 8/1/2023 | 27.58% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2023 | 19.8% |
Biodesix (BDSX) | 8/1/2023 | 17.21% |
Minerva Neurosciences (NERV) | 8/1/2023 | 12.22% |
Quantum BioPharma (QNTM) | 8/1/2023 | 11.86% |
Burning Rock Biotech (BNR) | 8/1/2023 | 11.76% |
Akebia Ther (AKBA) | 8/1/2023 | 9.52% |
In8bio (INAB) | 8/1/2023 | 9.17% |
vTv Therapeutics (VTVT) | 8/1/2023 | 7.99% |
Emergent Biosolutions (EBS) | 8/1/2023 | 7.62% |
Senti Biosciences (SNTI) | 8/1/2023 | 6.98% |
AEON Biopharma (AEON) | 8/1/2023 | 6.85% |
Alaunos Therapeutics (TCRT) | 8/1/2023 | 6.82% |
Surrozen (SRZN) | 8/1/2023 | 6.6% |
GH Research (GHRS) | 8/1/2023 | 6.55% |
Immatics (IMTX) | 8/1/2023 | 6.5% |
Greenwich Lifesciences (GLSI) | 8/1/2023 | 6.46% |
SAB Biotherapeutics (SABS) | 8/1/2023 | 6.25% |
OKYO Pharma Ltd ADR (OKYO) | 8/1/2023 | 5.88% |
Lite Strategy (LITS) | 8/1/2023 | 5.83% |
Intensity Therapeutics, Inc Common stock (INTS) | 8/1/2023 | 5.69% |
XBiotech (XBIT) | 8/1/2023 | 5.53% |
Olema Pharmaceuticals (OLMA) | 8/1/2023 | 5.34% |
Sagimet Biosciences Inc Series A Common Stock (SGMT) | 8/1/2023 | 5.33% |
Vor Biopharma (VOR) | 8/1/2023 | 5.32% |
